• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Small Innovators & Niche CROs

    Focus on Science

    Rapid and Data Rich Chromatographic Method Development

    Preparing Your Post Pandemic Talent Strategy

    How Modern Near-Infrared Came to Be
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Waters and Genovis Enter Biopharmaceutical Partnership

    Frontage Acquires Ocean Ridge Biosciences

    AGC Biologics Expands Partnership with Rocket Pharmaceuticals

    TraceLink Introduces Opus Platform

    Evotec to Build Second Biologics Mfg. Facility in Toulouse
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Evotec to Build Second Biologics Mfg. Facility in Toulouse

    Abenza Chooses North Carolina for New Biologics Manufacturing Site

    Catalent Adds Cryogenic Capabilities at Philadelphia Facility

    Recro, Ensysce Expand Development and Manufacturing Partnership

    Metrics Names Stephanie Emory Associate Director of Pharma Development
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    TraceLink Introduces Opus Platform

    Obituary Notice: Russell “Russ” Haines

    Catalent Adds Cryogenic Capabilities at Philadelphia Facility

    Cryoport Acquires Critical Transport Solutions Australia

    PharmParts – This Makes Sense!
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Decentralized Clinical Trials: The 101 on Digital Health Technologies (DHTs)

    Lessons Learned: Choosing and Managing a CDMO

    Waters and Genovis Enter Biopharmaceutical Partnership

    AGC Biologics Expands Partnership with Rocket Pharmaceuticals

    TraceLink Introduces Opus Platform
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Ensuring Pharma Manufacturing Quality

    What Will Change at FDA for 2021?

    RBQM Comes of Age: COVID as a Catalyst for Change

    Post-Pandemic Regulations

    Enteris BioPharma: Custom Solutions – From Bench to Market
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Baxter BioPharma Solutions

    PCI Pharma Services

    Adare Pharma Solutions

    Reed-Lane

    Emergent BioSolutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Emergent BioSolutions

    Alcami

    Aphena Pharma Solutions

    Adare Pharma Solutions

    Baxter BioPharma Solutions
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    Newsmakers: Vigene Biosciences

    Dr. Jeffrey Hung, Chief Commercial Officer, discusses Vigene’s new $20 million lab and strategic partnership with ASC Therapeutics

    Newsmakers: Vigene Biosciences
    Kristin Brooks, Contract Pharma02.20.20

    Vigene Biosciences recently opened its $20 million, state-of-the-art lab and research facility, and global headquarters in Rockville, MD. Vigene has also entered a major strategic partnership with the California gene therapy company, ASC Therapeutics. 

    Vigene provides viral vector-based gene delivery services and products; its mission to make gene therapy affordable. The company streamlines virus production from early conceptual stages to commercial manufacturing. The new 71-thousand square foot facility combines new manufacturing technologies and high yield production cell lines with the rigorous quality of cGMP and BSL-3.

    Under the long-term partnership with ASC Therapeutics, Vigene will provide GMP manufacturing, including viral vectors and plasmid DNA, for its hemophilia A gene therapy clinical program, as well as a manufacturing platform for future gene therapy programs.

    Vigene is listed on Inc. 5000 fastest-growing private companies in America for 2019 and 2018, named the 2018 ACG Emerging Company of the Year. The company started in Rockville, MD in 2012 with just five biotech experts. The company now employs 100, with plans to add as many as 80 more scientists, researchers and staff in the next year.

    Contract Pharma talks with Dr. Jeffrey Hung, Chief Commercial Officer of Vigene Biosciences, about the strategic partnership, supporting manufacturing, and the future of cell and gene therapies. –KB

    Contract Pharma: What are the main goals of the Vigene/ASC partnership?

    Jeffrey Hung: The main goals of the Vigene/ASC partnership are twofold. First, we plan to support the current ASC clinical trial material manufacturing. The second goal is to provide the availability for GMP manufacturing capacity for the future clinical trial and commercial manufacturing for ASC. This partnership is an endorsement to Vigene’s GMP manufacturing capacity and capability for viral vectors in that ASC entrusts to Vigene for not only one project but also their pipeline of current and future gene therapy candidates.

    CP: What are the current manufacturing challenges and how can they be overcome?

    JH: This is a billion dollar question. The manufacturing challenges lie throughout the process.  Cell line productivity, upstream production, downstream purification, analytical services and QC testing. The solution is innovation, optimization and scaleup. Let me address them one by one from Vigene’s experiences.

    Regarding innovation, we developed Vigene proprietary GMP level high productivity cell lines for viral vector production that has been demonstrated to be 2-3X more productive than current cell lines used by others. Regarding optimization, both the upstream process and downstream process can use more optimization to increase yield and reduce loss. From transfection we tested different transfection agents and different protocol, we have identified a protocol that generates 2-3X more productive than before. Regarding scaleup, Scaleup can save a lot on overhead, personnel and achieve lower cost per dose. To that end, Vigene built a state-of-the-art, up to 1000L, GMP production facility with full commercial production capability.

    CP: What do you anticipate for the future of cell and gene therapies?

    JH: We are only at the beginning of a new era. The future of cell and gene therapies is bright.  We are going to cure many diseases including both rare diseases and large indications through a new generation of cell and gene therapies. I see a few trends in the future of cell and gene therapies.

    The first one is that more and more pharma and biotech companies will develop a pipeline of cell and gene therapies to address a large set of unmet medical needs from rare diseases to cancer to Parkinson diseases. The second trend is that the manufacturing capacity will continue to expand to meet the demand from biotech and pharma companies. The favorable safety profile of AAV will prove very useful to translate a gene therapy concept to a clinical candidate quickly to benefit patients. Lastly, is the continued innovation both on the manufacturing process and basic viral vector biology to make gene therapy more accessible and affordable to the public. Vigene is definitely focused on this mission.



    Jeffrey Hung, Ph.D.
    Jeffrey Hung, Ph.D., is Chief Commercial Officer of Vigene Biosciences, a leading gene delivery company whose mission is to make gene therapy affordable. Dr. Hung orchestrated Vigene Biosciences’s acquisition of Omnia Biologics in 2016, a CMO specializing on GMP manufacturing of Viruses. Dr. Hung served as the Vice President of GenScript and was instrumental in growing the company before the IPO in December 2015. Dr. Hung was the Chief Marketing Officer at ATCC, the world’s largest biobank, before joining GenScript. Dr. Hung is the author of multiple patents, peer reviewed publications. Dr. Hung earned his Ph.D. from Cornell University, MBA from UC Berkeley, and BS from Peking University.
    Related Searches
    • production
    • contract pharma
    • Pharma
    • pharma companies

    Related Online Exclusives

    • Biologics, Proteins, Vaccines | cGMP Manufacture
      Advanced Analytics Advancing Development of Genetic Vaccines

      Advanced Analytics Advancing Development of Genetic Vaccines

      Leveraging innovative advanced analytical technologies to ensure regulatory compliance in the development and production of novel vaccines.
      Kristin Brooks, Managing Editor, Contract Pharma 03.29.21

    • Biologics, Proteins, Vaccines | Clinical Trials
      Inside a COVID Vaccine Trial

      Inside a COVID Vaccine Trial

      Dr. Murphy of ICON, provider of clinical services to Pfizer/BioNTech’s COVID vaccine program, discusses what it takes to conduct a vaccine trial of this scale.
      Kristin Brooks, Managing Editor 02.05.21

    • Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development
      The Future of Vaccines and Biologics

      The Future of Vaccines and Biologics

      Dr. Linda Marbán of Capricor Therapeutics discusses the advances in responding to infectious diseases.
      Kristin Brooks, Managing Editor, Contract Pharma 02.04.21


    • Analytical Services | Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development | Fill/Finish
      A New Era of Vaccine and Biologic Drug Development

      A New Era of Vaccine and Biologic Drug Development

      As a result of COVID-19, unprecedented investments in vaccines, diagnostics, and treatments have had a tremendous impact on the Biotechnology industry.
      Kristin Brooks, Managing Editor 01.12.21

    • Biologics, Proteins, Vaccines
      India Emerges as Hot Spot for Manufacturing COVID-19 Vaccines

      India Emerges as Hot Spot for Manufacturing COVID-19 Vaccines

      CMOs expand and ‘repurpose’ capacities.
      S Harachand, Contributing Editor 10.20.20

    • Biologics, Proteins, Vaccines | Drug Development | Regulatory Affairs
      Expediting a COVID-19 Vaccine: FDA Approval Process

      Expediting a COVID-19 Vaccine: FDA Approval Process

      The pressures of the pandemic are pushing sponsors and FDA to look at both efficacy and speed in developing a vaccine.
      Kristin Brooks, Contract Pharma 08.25.20


    • Biologics, Proteins, Vaccines | Drug Discovery
      Cell Therapy for Solid Tumors

      Cell Therapy for Solid Tumors

      Is base editing the solution for solid tumor-based cell therapy?
      Jonathan Frampton, Corporate Development Partner, Horizon Discovery 06.26.20

    • Analytical Services | Biologics, Proteins, Vaccines | Drug Development | Drug Discovery | Laboratory Testing
      A Shifting Drug Development Landscape Amid COVID-19 Crisis

      A Shifting Drug Development Landscape Amid COVID-19 Crisis

      Responding to demand for challenging assays and custom solutions required for complex molecules, biologics, vaccines and other innovative therapies.
      Kristin Brooks, Contract Pharma 06.22.20

    • Biologics, Proteins, Vaccines | cGMP Manufacture | Clinical Trials | Drug Development | Scale-up/Technology Transfer
      Rapid Delivery of Medical Countermeasures Amid Pandemic

      Rapid Delivery of Medical Countermeasures Amid Pandemic

      Robert Erwin of iBio discusses the company’s COVID-19 vaccine development efforts and FastPharming manufacturing platform for the rapid delivery of vaccines
      Kristin Brooks, Contract Pharma 04.03.20


    • Biologics, Proteins, Vaccines | Clinical Trials | Drug Development
      COVID-19 Vaccine Response

      COVID-19 Vaccine Response

      ICON execs discuss developments in vaccine research efforts and key challenges of delivering a coronavirus vaccine
      Kristin Brooks, Contract Pharma 04.01.20

    • Biologics, Proteins, Vaccines | cGMP Manufacture | Clinical Trial Materials | Drug Development
      Newsmakers: Thermo Fisher Scientific

      Newsmakers: Thermo Fisher Scientific

      Leon Wyszkowski discusses the company’s recent investments, the challenges biopharma companies face, and future needs in the outsourcing space
      03.16.20

    • Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Drug Development
      COVID-19 Clinical Trials

      COVID-19 Clinical Trials

      The vaccines in development for COVID-19, who's developing them, and where they stand in the development process
      Kristin Brooks, Contract Pharma 03.10.20


    • Biologics, Proteins, Vaccines | Clinical Trials | Drug Development | Industry News
      Outsourcing in the Cell & Gene Therapy Space

      Outsourcing in the Cell & Gene Therapy Space

      Specialized and coordinated capabilities aim to accelerate drug development and reduce risk for sponsors
      Kristin Brooks, Contract Pharma 02.04.20

    • Aseptic Processing | Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development | Fill/Finish | Parenterals
      Contract Pharma’s 20th Anniversary Series: Vetter

      Contract Pharma’s 20th Anniversary Series: Vetter

      Oskar Gold of Vetter discusses vital changes in the industry and the science and technology needed to support advanced therapeutics
      Kristin Brooks, Contract Pharma 11.13.19

    • Analytical Services | Bioanalytical Services | Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development | Formulation Development
      Contract Pharma’s 20th Anniversary Series: Ajinomoto Bio-Pharma

      Contract Pharma’s 20th Anniversary Series: Ajinomoto Bio-Pharma

      David Enloe of Ajinomoto Bio-Pharma Services shares his perspective on market changes over the years and the evolution of more integrated outsourcing
      Kristin Brooks, Contract Pharma 11.11.19

    Trending
    • Pfizer, BioNTech Expand COVID-19 Vaccine Agreement With EU
    • Franco Negron Named CEO Of ApiJect Systems America
    • Obituary Notice: Russell “Russ” Haines
    • Resilience Acquires Ology Bioservices
    • Johnson & Johnson 1Q Results
    Breaking News
    • Waters and Genovis Enter Biopharmaceutical Partnership
    • Frontage Acquires Ocean Ridge Biosciences
    • AGC Biologics Expands Partnership with Rocket Pharmaceuticals
    • TraceLink Introduces Opus Platform
    • Evotec to Build Second Biologics Mfg. Facility in Toulouse
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Small Innovators & Niche CROs
    • Focus on Science
    • Rapid and Data Rich Chromatographic Method Development
    • Preparing Your Post Pandemic Talent Strategy
    • How Modern Near-Infrared Came to Be
    • Securing Your API Supply Chain: Three Keys to Success
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Innova Market Insights: Sports Nutrition Must Focus on Flavors for Mainstream Consumers
    Probiotic Strain Evidenced to Reduce Iron Deficiency/Anemia Risk
    Longvida Curcumin Extract Receives ANVISA Approval in Brazil
    Coatings World

    Latest Breaking News From Coatings World

    Keim-additec Hires Tyler John as Technical Sales Manager
    Nouryon Appoints Julie Aslaksen to Board of Directors
    RadTech Announces New Board Members, Secretary, Honorary Lifetime Member
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    J&J’s Veritas Vision System Receives FDA Clearance and CE Mark
    Viz.ai’s AI-Powered Platform Can Improve Outcomes for Stroke Patients
    FDA Breakthrough Device Designation Granted for pdSTIM System
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Waters and Genovis Enter Biopharmaceutical Partnership
    Frontage Acquires Ocean Ridge Biosciences
    AGC Biologics Expands Partnership with Rocket Pharmaceuticals
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    How Do Americans Feel About Diversity in Beauty Advertising?
    Estée Lauder Companies Reaffirms Sustainability Goals for Earth Month
    Coty’s Lancaster Earns C2C Certified Material Health Certificate
    Happi

    Latest Breaking News From Happi

    FDA Cites Disinfection Issues at Proposed Vaccine Production Site
    It's Official! L'Oréal Gets New CEO on May 1
    New Beauty Brand sk*p Wants to Break Addiction to Plastic
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    SE-DA Invests in Kornit Presto S
    Acrylic Resins Market Worth $21.9 Billion by 2025: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Global Graphics unveils new SmartDFE
    Channeled Resources installs new slitter in Toronto facility
    Kao Collins launches new website for printing inks and services
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    FiberVisions, Avgol Partner with Polymateria
    High-Tech Conversation Launches Wipes Dispenser
    Because Market Debuts Premium Plus Line
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Patients Conclude Clinical Visits in Knee Osteoarthritis Treatment Study
    SeaSpine Begins Limited Rollout of WaveForm TO 3D-Printed Interbodies
    Spinal Elements' Lucent 3D Additive Manufactured Interbodies Earn FDA Nod
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    SEMI Appoints imec, Soitec Executives to Europe Advisory Board
    TechBlick Announces Agenda For Next Printed, Hybrid, Structural, 3D Electronics Virtual Event
    NREL Takes Novel Approach to 3D-Printed Water Power Prototypes

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login